Developing Personalised Relative Physical Activity Thresholds in COPD.
IMPACT
Developing Personalised, Relative Intensity Physical Activity Thresholds for Accelerometer-Derived Measures of Physical Activity in COPD (IMPACT)
2 other identifiers
observational
70
1 country
1
Brief Summary
The aim of this observational study is to translate the principle of individualised exercise prescription into the evaluation of daily absolute and relative intensity physical activity. The main questions this study aims to answer are:
- Phase 1: What does physical activity (intensity) mean to people with COPD?
- Phase 2: Are there differences between time spent in absolute and relative physical activity for people with COPD? Phase 1 Participants will take part in semi-structured interview (30-45 minutes) about living with COPD and perceptions of physical activity and how they perceive intensity. This will also include photovoice and photo-elicitation. Demographic information will be recorded and participants will also complete several respiratory symptom questionnaires. Phase 2: Participants will take part in physical activity testing before and after pulmonary rehabilitation while wearing physical activity monitors. Demographic information will be recorded and participants will also complete several respiratory symptom and physical activity questionnaires. Participants will also wear the physical activity monitors for 8 days after the pre-testing sessions and after their final pulmonary rehabilitation class. Sub-study: Participants will be asked to take images of barriers during physical activity, facilitators during physical activity, feelings during physical activity and types of physical activity they take part in for 8 days after their final pulmonary rehabilitation class. Participants will then take part in a semi-structured interview about the images their have taken while doing physical activity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 22, 2023
CompletedFirst Submitted
Initial submission to the registry
March 4, 2024
CompletedFirst Posted
Study publicly available on registry
March 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedSeptember 19, 2024
September 1, 2024
1.4 years
March 4, 2024
September 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Phase 1 - Semi-structured Interviews
Semi-structured interview with individuals with COPD
30-45 minutes
Phase 2 - Differences between time spent in PA intensity expressed in absolute and relative intensity.
Differences between time spent in PA intensity expressed in absolute and relative using activity monitors (wrist and waist) for eight days before and after the PR programme.
8 days
Secondary Outcomes (12)
Phase 1 - Medical Research Council (MRC) Dyspnoea Scale
2 minutes
Phase 1 - COPD Assessment Test (CAT)
5 minutes
Phase 1 - Chronic Respiratory Questionnaire (CRQ-SR)
5 minutes
Phase 1 - Photovoice and photo-elicitation
7 days
Phase 2 - Medical Research Council (MRC) Dyspnoea Scale
2 minutes
- +7 more secondary outcomes
Study Arms (2)
Phase 1 Cohort
These participants will be recruited from: * Previous research studies * COPD nursing ward * Pulmonary rehabilitation
Phase 2 Cohort
These participants will be recruited from the pulmonary rehabilitation service.
Eligibility Criteria
Phase 1: Patients from the COPD nursing ward, previous research studies and pulmonary rehabilitation programme. Phase 2: Patients from the pulmonary rehabilitation programme.
You may qualify if:
- Willing and able to provide informed consent for participation in the research.
- The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria (Agustà et al., 2023).
- Male or female, aged 40+ years
- Able to communicate in written and spoken English.
You may not qualify if:
- Unable to provide valid informed consent.
- Severe psychiatric disorders
- Aged less than 40 years
- Unable to understand written or spoken English.
- Phase 2:
- Willing and able to provide informed consent for participation in the research.
- The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria.
- The patient is referred for PR at the UHL.
- Male or female, aged 40+ years
- Able to communicate in written and spoken English
- Unable to provide valid informed consent.
- Lack of motivation to participate in PR programme.
- Any-contra-indications absolute or relative to exercise training.
- Has had a cardiac event within last 6 weeks
- Severe psychiatric disorders
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NIHR Leicester Biomedical Research Centre - Respiratory
Leicester, Leicestershire, LE67 2DU, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
University of Leicester University of Leicester
University of Leicester
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2024
First Posted
March 26, 2024
Study Start
November 22, 2023
Primary Completion
March 30, 2025
Study Completion
September 1, 2025
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share
The data will only be available in publications.